Gaps in access to palliative care services mean that many patients with life-limiting illnesses miss out on support they need, but there is much to learn about people’s experiences at the end of life.
Statins have been a mainstay of heart attack and stroke prevention for the past 20 years, but the race is on to bring a new drug to market that targets an enzyme called PCSK9.
A debate over whether saturated fat is bad for cardiovascular health has surfaced once again. The evidence still stands: its consumption should be limited.
Deputy chief pharmaceutical officer Bruce Warner discusses promoting the medicines optimisation agenda and shares his views on broader issues affecting pharmacists.
If a complaint is brought against a pharmacist in the UK, what can he or she expect from the fitness-to-practise process? Ailsa Colquhoun explains.
Meta-analysis casts doubt over first-line paracetamol use for back pain and osteoarthritisSubscription
A meta-analysis published in The BMJ has cast doubt on the use of paracetamol as the first-line analgesic for spinal pain and osteoarthritis of the hip and knee.
FDA fights opioid abuse with industry guidanceSubscription
Measures to limit the abuse of opioid drugs have been issued by the US Food and Drug Administration in guidance for the pharmaceutical industry.
News in Brief
EMA fast tracks approval of thyroid cancer drugSubscription